Study: sBTLA proteins potential marker of overall survival of liver cancer patients
Researchers at the Department of Hepatology of Osaka City University Graduate School of Medicine introduced sorafenib to patients with advanced stages of the liver cancer hepatocellular carcinoma (HCC) and measured the amount ...
Mar 9, 2020
0
0